Avinger Inc
NASDAQ:AVGR
Intrinsic Value
Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with... [ Read More ]
The intrinsic value of one AVGR stock under the Base Case scenario is 17.97 USD. Compared to the current market price of 3.93 USD, Avinger Inc is Undervalued by 78%.
Valuation Backtest
Avinger Inc
Run backtest to discover the historical profit from buying and selling AVGR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Avinger Inc
Current Assets | 12.2m |
Cash & Short-Term Investments | 5.3m |
Receivables | 1m |
Other Current Assets | 5.9m |
Non-Current Assets | 1.6m |
PP&E | 1.6m |
Other Non-Current Assets | 19k |
Current Liabilities | 19.3m |
Accounts Payable | 777k |
Accrued Liabilities | 4.2m |
Other Current Liabilities | 14.3m |
Non-Current Liabilities | 672k |
Other Non-Current Liabilities | 672k |
Earnings Waterfall
Avinger Inc
Revenue
|
7.7m
USD
|
Cost of Revenue
|
-5.6m
USD
|
Gross Profit
|
2m
USD
|
Operating Expenses
|
-18.6m
USD
|
Operating Income
|
-16.6m
USD
|
Other Expenses
|
-1.7m
USD
|
Net Income
|
-18.3m
USD
|
Free Cash Flow Analysis
Avinger Inc
What is Free Cash Flow?
AVGR Profitability Score
Profitability Due Diligence
Avinger Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Avinger Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
AVGR Solvency Score
Solvency Due Diligence
Avinger Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Avinger Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AVGR Price Targets Summary
Avinger Inc
According to Wall Street analysts, the average 1-year price target for AVGR is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
Ownership
AVGR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
AVGR Price
Avinger Inc
Average Annual Return | -57.83% |
Standard Deviation of Annual Returns | 33.49% |
Max Drawdown | -100% |
Market Capitalization | 6.7m USD |
Shares Outstanding | 1 702 230 |
Percentage of Shares Shorted | 3.39% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. The company is headquartered in Redwood City, California and currently employs 74 full-time employees. The company went IPO on 2015-01-30. The firm designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its image-guided Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. The company has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris SV (Small Vessel).
Contact
IPO
Employees
Officers
The intrinsic value of one AVGR stock under the Base Case scenario is 17.97 USD.
Compared to the current market price of 3.93 USD, Avinger Inc is Undervalued by 78%.